Aphria (NYSE:APHA) is down 11% year-to-date but that situation is likely to reverse. That is because Aphria is one of the only cannabis stocks that is profitable. Its profitability will increase next ...

For a well-known asset listed on the New York Stock Exchange, Aphria stock is surprisingly affordable and could easily fit into practically anyone’s budget. Don’t be tricked into thinking that cheap ...

On the one hand, it’s tempting to dismiss Aphria’s results as not being a big deal. Aphria is a scandal-plagued company whose former management quit. Short sellers attacked the company for allegedly ...

The legal cannabis industry is still in the early innings of growth and as such, it is fragmented, fraught with risk and also chock full of potentially compelling growth stories. As legal marijuana is ...

If you're a value investor, neither one of these marijuana stocks looks attractive. Aphria stock trades at 136 times sales, while MedReleaf's price-to-sales ratio is nearly 56. But no marijuana stock ...

** Aphria's U.S.-listed shares climb 12 pct to $6.24 premarket vs. Green Growth Brands Ltd's planned offer price of C$11, or $8.09 at current forex rates ** Aphria's Toronto-listed shares closed at ...

(Reuters) - U.S. cannabis retailer Green Growth Brands Inc said on Tuesday it would make a second all-stock takeover bid for Aphria Inc , valuing the Canadian pot producer at about C$2.35 billion ...